Fuchs内皮性角膜营养不良患者报告视觉残疾:V-FUCHS问卷验证
本研究验证了新型患者报告视觉残疾问卷V-FUCHS在Fuchs内皮性角膜营养不良(FECD)及内皮角膜移植(EK)前后的适用性。横断面研究纳入FECD不同严重程度、EK术后及健康角膜患者,显示问卷具有良好信效度,可区分视力与眩光/昼夜变异两个独立因素。
要点
- V-FUCHS问卷在FECD中提取出视力相关7项和眩光/昼夜变异相关8项两个独立因素。
- 重测信度良好(组内相关系数≥0.8),视力因素与Catquest-9SF评分相关(r=0.65,P<0.001)。
- 眩光/昼夜变异因素随FECD严重程度增加(P<0.001),且FECD患者高于健康对照(P<0.001)。
核心结论
- V-FUCHS问卷是评估FECD患者视觉残疾的有效且可靠的工具,可作为患者报告结局指标用于临床和研究。
研究设计与样本
- 横断面研究,并在6周时重新施测问卷以评估重测信度。
- 纳入不同严重程度的FECD患者(n=41)、FECD行内皮角膜移植术后患者(n=70)及健康角膜对照(n=28)。
主要发现
- 探索性因子分析显示FECD及EK术后患者存在两个独立视觉残疾因素:7项与视力相关,8项与眩光或昼夜变异相关。
- 重测信度良好,两个因素的组内相关系数均≥0.8。
- 视力因素与Catquest-9SF评分相关(r=0.65;P<0.001;n=96)。
- 眩光或昼夜变异因素随FECD严重程度增加(P<0.001,n=69),且FECD患者高于健康参与者(P<0.001)。
- Rasch模型诊断显示两个因素均校准良好并符合模型预期。
关键数值与推荐
- 重测信度:组内相关系数≥0.8(两个因素)。
- 视力因素与Catquest-9SF评分相关系数r=0.65(P<0.001,n=96)。
- 眩光或昼夜变异因素随FECD严重程度增加(P<0.001,n=69),FECD患者高于健康对照(P<0.001)。
临床怎么用
- V-FUCHS可用于FECD患者疾病特异性视觉残疾的标准化、全面且快速评估,辅助判断干预时机及评估干预结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Measuring patient-reported visual disability in Fuchs' endothelial corneal dystrophy (FECD) may be helpful in determining when to intervene and for understanding the outcomes of intervention. In this study, we aimed to validate a new patient-reported visual disability questionnaire, the Visual Function and Corneal Health Status (V-FUCHS) instrument, in FECD before and after endothelial keratoplasty (EK). DESIGN: Cross-sectional study with instrument readministration at 6 weeks. PARTICIPANTS: Patients with a range of severity of FECD, including after EK, and patients with healthy corneas. METHODS: The V-FUCHS instrument was developed based on patient interviews, expert consultations, and pretesting. Psychometric methods of classic test theory were applied to estimate reliability and validity, including testing V-FUCHS against Catquest-9SF, a cataract-specific visual disability questionnaire. Ordered polytomous Rasch-based partial credit models and item response theory diagnostics were used to define the response patterns. MAIN OUTCOME MEASURES: Reliability (primary) and validity (secondary). RESULTS: The final instrument was completed by 65% of patients with a range of severity of FECD (n = 41), after undergoing EK for FECD (n = 70), and with healthy corneas (n = 28). Participants were phakic or pseudophakic. Exploratory factor analysis among FECD and patients who underwent EK showed 2 independent factors of visual disability: 7 items related to visual acuity and 8 items related to glare or diurnal variation. Retest reliability was substantial (intraclass correlation coefficient, ≥0.8, both factors). Among all patients, the visual acuity factor was correlated with Catquest-9SF scores (r = 0.65; P < 0.001; n = 96). The glare or diurnal variation factor increased with FECD severity (P < 0.001, n = 69) and was higher in FECD than healthy participants (P < 0.001). Diagnostics revealed that both factors were well calibrated and met Rasch model expectations. CONCLUSIONS: The V-FUCHS instrument is valid and reliable for assessing visual disability in FECD. The instrument allows for standardized, comprehensive, and rapid assessment of disease-specific visual disability and may be useful in clinical practice and research as a patient-reported outcome measure.
引用
- Wacker K, Baratz KH, Bourne WM, et al. Patient-Reported Visual Disability in Fuchs' Endothelial Corneal Dystrophy Measured by the Visual Function and Corneal Health Status Instrument. Ophthalmology. 2018. PMID: 30104038. doi:10.1016/j.ophtha.2018.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。